InvestSMART

PharmX Technologies Limited (ASX:PHX)

ALERT: Price-sensitive ASX Announcement for PHX
Current share price for PHX : $0.098 -0.047 (-32.41%)+
Announcement
Release
25 Feb 2026 8:26AM
Price at Release
$0.145
Full Release
download
Summary
PharmX Technologies Limited reported its half-year results for the period ending 31 December 2025, highlighting strategic investments that resulted in a net loss of $512,000, compared to a profit of $155,000 in the previous year. Despite increased investment in their Pharmx Single Platform, including the launch of a new Marketplace, revenue grew by 3% to $3,890,000. The company focused on enhancing its platform capabilities with StockView for better inventory visibility and transitioning existing suppliers to an improved Marketplace, which saw significant growth in transaction value. The strategic focus remains on expanding supplier partnerships, driving pharmacy engagement, and enhancing analytics capabilities. A notable post-reporting event includes a strategic alliance with Sigma Healthcare, which involves a multi-year partnership and equity investment by Sigma in PharmX.
Key Points
  • Net loss after income tax for the period was $512,000.
  • Revenue increased by 3% to $3,890,000.
  • Launch of the new Pharmx Marketplace with a focus on strategic investments.
  • Significant increase in personnel and marketing costs due to development and IT infrastructure investments.
  • Introduction of StockView for better inventory management.
  • Formation of a strategic alliance with Sigma Healthcare post-reporting period.
  • The company's strategic focus includes expanding supplier partnerships and enhancing analytics capabilities.
  • Total assets at the end of the period were $18,006,000.
  • Cash and cash equivalents decreased to $3,214,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.